Cargando…

Inflammation status modulates the effect of host genetic variation on intestinal gene expression in inflammatory bowel disease

More than 240 genetic risk loci have been associated with inflammatory bowel disease (IBD), but little is known about how they contribute to disease development in involved tissue. Here, we hypothesized that host genetic variation affects gene expression in an inflammation-dependent way, and investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Shixian, Uniken Venema, Werna T., Westra, Harm-Jan, Vich Vila, Arnau, Barbieri, Ruggero, Voskuil, Michiel D., Blokzijl, Tjasso, Jansen, Bernadien H., Li, Yanni, Daly, Mark J., Xavier, Ramnik J., Dijkstra, Gerard, Festen, Eleonora A., Weersma, Rinse K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892863/ https://www.ncbi.nlm.nih.gov/pubmed/33602935 http://dx.doi.org/10.1038/s41467-021-21458-z

Ejemplares similares

Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease
por: Bangma, Amber, et al.
Publicado: (2020)

Understanding human gut diseases at single-cell resolution
por: Bigaeva, Emilia, et al.
Publicado: (2020)

Donor genetic variants as risk factors for thrombosis after liver transplantation: A genome‐wide association study
por: Li, Yanni, et al.
Publicado: (2021)

HIF1α-Dependent Induction of TFRC by a Combination of Intestinal Inflammation and Systemic Iron Deficiency in Inflammatory Bowel Disease
por: Fagundes, Raphael R., et al.
Publicado: (2022)

SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects
por: Collij, Valerie, et al.
Publicado: (2019)

Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics
por: Voskuil, Michiel Dirk, et al.
Publicado: (2019)

The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease
por: Ruigrok, Renate A A A, et al.
Publicado: (2021)

Gut mucosa dissociation protocols influence cell type proportions and single-cell gene expression levels
por: Uniken Venema, Werna T. C., et al.
Publicado: (2022)

The emerging role of the small intestinal microbiota in human health and disease
por: Ruigrok, Renate A. A. A., et al.
Publicado: (2023)

Pirfenidone Inhibits Cell Proliferation and Collagen I Production of Primary Human Intestinal Fibroblasts
por: Cui, Yingying, et al.
Publicado: (2020)

Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn’s Disease Exacerbations
por: Klaassen, Marjolein A Y, et al.
Publicado: (2019)

Inulin-grown Faecalibacterium prausnitzii cross-feeds fructose to the human intestinal epithelium
por: Fagundes, Raphael R., et al.
Publicado: (2021)

Donor tobacco smoking is associated with postoperative thrombosis after primary liver transplantation
por: Li, Yanni, et al.
Publicado: (2020)

Isotype-specific Antibody Responses to Mycobacterium avium paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in Inflammatory Bowel Disease
por: van der Sloot, Kimberley W J, et al.
Publicado: (2020)

Gut microbiota in inflammatory bowel diseases: moving from basic science to clinical applications
por: Collij, Valerie, et al.
Publicado: (2020)

A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Whole exome sequencing analyses reveal gene–microbiota interactions in the context of IBD
por: Hu, Shixian, et al.
Publicado: (2021)

Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFα therapy in inflammatory bowel disease
por: Karmi, Naomi, et al.
Publicado: (2021)

Large-scale genetic analyses in an understudied disease: haemorrhoidal disease
por: Festen, Eleonora A M, et al.
Publicado: (2021)

TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease
por: Bangma, Amber, et al.
Publicado: (2021)

The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R, et al.
Publicado: (2021)

Faecal metabolome and its determinants in inflammatory bowel disease
por: Vich Vila, Arnau, et al.
Publicado: (2023)

Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease
por: Gabriëls, Ruben Y., et al.
Publicado: (2022)

Health-related quality of life is linked to the gut microbiome in kidney transplant recipients
por: Swarte, J. Casper, et al.
Publicado: (2023)

Environmental factors associated with biological use and surgery in inflammatory bowel disease
por: van der Sloot, Kimberley W J, et al.
Publicado: (2020)

Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients
por: Swarte, J. Casper, et al.
Publicado: (2020)

Diversity and Ecology of Caudoviricetes Phages with Genome Terminal Repeats in Fecal Metagenomes from Four Dutch Cohorts
por: Gulyaeva, Anastasia, et al.
Publicado: (2022)

Riboflavin Supplementation in Patients with Crohn’s Disease [the RISE-UP study]
por: von Martels, Julius Z H, et al.
Publicado: (2020)

Pharmacomicrobiomics: a novel route towards personalized medicine?
por: Doestzada, Marwah, et al.
Publicado: (2018)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease
por: Gacesa, R., et al.
Publicado: (2021)

Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome
por: Bolte, Laura A, et al.
Publicado: (2021)

Role of the gut microbiome in mediating lactose intolerance symptoms
por: Brandao Gois, M F, et al.
Publicado: (2022)

The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1
por: Imhann, Floris, et al.
Publicado: (2019)

Correction to: The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1
por: Imhann, Floris, et al.
Publicado: (2019)

Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Exome sequencing in patient‐parent trios suggests new candidate genes for early‐onset primary sclerosing cholangitis
por: Haisma, Sjoukje‐Marije, et al.
Publicado: (2021)

Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome
por: Chen, Lianmin, et al.
Publicado: (2022)

Intestinal stenosis in Crohn’s disease shows a generalized upregulation of genes involved in collagen metabolism and recognition that could serve as novel anti-fibrotic drug targets
por: van Haaften, Wouter Tobias, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5oppshnfgokamoqssmocikfoff